Pharmacist tracking and correction of medication errors: An improvement project in the observation ward of the emergency department.

Clinical pharmacist Conciliation médicamenteuse Erreurs médicamenteuses Gestion de risque Medication errors Medication reconciliation Observation ward Pharmacien clinicien Risk management Unité d’hospitalisation de courte durée

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 12 07 2022
revised: 19 06 2023
accepted: 21 06 2023
pubmed: 26 6 2023
medline: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

The risk of medication errors is high in emergency departments. Implementation of medication reconciliation activity complemented by pharmaceutical analysis of prescription is an effective way to reduce drug related problems. This study aimed to assess the potential clinical impact of these activities to prevent medication errors for the observation ward patients. The secondary objective was to assess these activities' cost-avoidance and benefit-to-cost ratio. This study was conducted in a 16-bed unit, over a 5-month period. The patients' demographic and treatment details, and data from pharmaceutical activities were collected and analyzed by a pharmacist. Two pharmacists and an emergency physician assessed the potential clinical impact of medication errors. Medication reconciliation for 250 patients (15.7% of 1589 admitted patients) and pharmaceutical analysis of prescription for 302 patients (19%) were performed by the pharmacist. Medication reconciliation detected 752 errors in 197 patients; 19% were related to high-risk medications and 14% had a potential clinical impact assessed as major, critical or fatal. Pharmaceutical analysis of prescription revealed 159 drug related problems in 118 patients; of which 26% involved high-risk medications and 24% had a potential clinical impact assessed "at least major". In total, 16% of pharmacist interventions had a potential clinical impact assessed "at least major" in 33% of patients: this represents 1.8 pharmacist interventions formulated per day. The presence of a pharmacist in the observation ward of the emergency department is useful in detecting iatrogenic drug related problems and reducing their medical impact. The benefit-to-cost ratio is favorable for the hospital.

Identifiants

pubmed: 37356662
pii: S0003-4509(23)00067-6
doi: 10.1016/j.pharma.2023.06.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1007-1017

Informations de copyright

Copyright © 2023 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Johanna Raymond (J)

Pharmacy Department, CHU Rouen, Rouen, France; Observation ward, Adult Emergency Department, CHU Rouen, 76000 Rouen, France. Electronic address: johanna.raymond@chu-rouen.fr.

Pierre Parrein (P)

Pharmacy Department, CHU Rouen, Rouen, France.

Eric Barat (E)

Pharmacy Department, CHU Rouen, Rouen, France.

Catherine Chenailler (C)

Pharmacy Department, CHU Rouen, Rouen, France.

Gaëlle Decreau-Gaillon (G)

Observation ward, Adult Emergency Department, CHU Rouen, 76000 Rouen, France.

Rémi Varin (R)

Pharmacy Department, CHU Rouen, Rouen, France.

Luc-Marie Joly (LM)

Observation ward, Adult Emergency Department, CHU Rouen, 76000 Rouen, France.

Classifications MeSH